These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10082034)

  • 1. Hope for a cure through earlier detection of hepatocellular cancer.
    Sitzmann JV
    Ann Surg Oncol; 1999 Mar; 6(2):133-4. PubMed ID: 10082034
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum tests for diagnosis and follow-up of hepatocellular carcinoma after treatment.
    Trojan J; Raedle J; Zeuzem S
    Digestion; 1998 Jul; 59 Suppl 2():72-4. PubMed ID: 9718428
    [No Abstract]   [Full Text] [Related]  

  • 3. Candidate biomarkers for liver cancer.
    Cottingham K
    J Proteome Res; 2009 Feb; 8(2):428. PubMed ID: 19271311
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening and detection of hepatocellular carcinoma.
    Simpson HN; McGuire BM
    Clin Liver Dis; 2015 May; 19(2):295-307. PubMed ID: 25921664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-fetoprotein in hepatocellular carcinoma surveillance: wake not the dead.
    Giannini EG; Farinati F; Trevisani F
    Hepatology; 2011 Jul; 54(1):376-7. PubMed ID: 21710475
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatocellular carcinoma tumour markers: current role and expectations.
    Rich N; Singal AG
    Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):843-53. PubMed ID: 25260312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum TGF-β1: A Potential Biomarker for Early Detection of Hepatocellular Carcinoma.
    He J; Liu Y
    EBioMedicine; 2016 Oct; 12():4-5. PubMed ID: 27665049
    [No Abstract]   [Full Text] [Related]  

  • 8. A novel, rapid, and sensitive homogeneous sandwich detection method of Glypican-3 as a serum marker for hepatocellular carcinoma.
    Han N; Wang W; Lu D; Wang H; Ma X; Fan X; Li F
    Chem Commun (Camb); 2017 Nov; 53(90):12209-12212. PubMed ID: 29077109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ASO Author Reflections: Annexin A3 as a Potential Biomarker for Hepatocellular Carcinoma.
    Yang XR; Guo W
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):529-530. PubMed ID: 30519762
    [No Abstract]   [Full Text] [Related]  

  • 10. New, effective treatment using proton irradiation for unresectable hepatocellular carcinoma.
    Matsuzaki Y; Osuga T; Chiba T; Saito Y; Tanaka N; Itai Y; Tsujii H
    Intern Med; 1995 Apr; 34(4):302-4. PubMed ID: 7606109
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum tumor markers for detection of hepatocellular carcinoma.
    Zhou L; Liu J; Luo F
    World J Gastroenterol; 2006 Feb; 12(8):1175-81. PubMed ID: 16534867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison between alpha-fetoprotein and p53 antibodies in the diagnosis of hepatocellular carcinoma.
    Edis C; Kähler C; Klotz W; Herold M; Feichtinger H; Königsreiner A; Margreiter R; Jaschke W; Vogel W
    Transplant Proc; 1998 May; 30(3):780-1. PubMed ID: 9595095
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatocellular carcinoma surveillance with miRNAs.
    Forner A
    Lancet Oncol; 2015 Jul; 16(7):743-5. PubMed ID: 26088271
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of long non-coding RNA p34822 as a potential plasma biomarker for the diagnosis of hepatocellular carcinoma.
    Wang C; Ren T; Wang K; Zhang S; Liu S; Chen H; Yang P
    Sci China Life Sci; 2017 Sep; 60(9):1047-1050. PubMed ID: 28547580
    [No Abstract]   [Full Text] [Related]  

  • 15. History and recent progress in evaluation of the fucosylated alpha-fetoprotein fraction.
    Aoyagi Y; Tamura Y; Suda T
    J Gastroenterol Hepatol; 2011 Apr; 26(4):615-6. PubMed ID: 21418297
    [No Abstract]   [Full Text] [Related]  

  • 16. Contribution of biomarkers and imaging in the management of hepatocellular carcinoma.
    Fartoux L; Decaens T
    Clin Res Hepatol Gastroenterol; 2011 Jun; 35 Suppl 1():S21-30. PubMed ID: 21742297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Des-gamma-carboxyprothrombin in hepatocellular carcinoma after vitamin K1 injection.
    Buffet C; Bismuth E; Hagege H; Etienne JP
    Dig Dis Sci; 1989 Jun; 34(6):963-4. PubMed ID: 2470560
    [No Abstract]   [Full Text] [Related]  

  • 18. Extremely High Preoperative Alpha-Fetoprotein Level Is Associated with Vascular Invasion, Non-R0 Resection, and Poor Prognosis in Hepatocellular Carcinoma Patients.
    Zhang Y; Huang P; Zheng Y; Wang Y; Yuan Y; He W; Liu W; Yang Z; Wang C; Yuan Y; Li B
    Am Surg; 2019 Jun; 85(6):e309-e312. PubMed ID: 31267923
    [No Abstract]   [Full Text] [Related]  

  • 19. Alpha-l-Fucosidase Immunoassay for Early Detection of Hepatocellular Carcinoma.
    Waidely E; Al-Youbi AO; Bashammakh AS; El-Shahawi MS; Leblanc RM
    Anal Chem; 2017 Sep; 89(17):9459-9466. PubMed ID: 28727913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating microRNAs in Hepatocellular Carcinoma: Potential Diagnostic and Prognostic Biomarkers.
    Mirzaei HR; Sahebkar A; Mohammadi M; Yari R; Salehi H; Jafari MH; Namdar A; Khabazian E; Jaafari MR; Mirzaei H
    Curr Pharm Des; 2016; 22(34):5257-5269. PubMed ID: 26935703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.